Pharmaniaga aims to supply Sinovac vaccine to markets in Southeast Asia, Africa

KUALA LUMPUR: Pharmaniaga Bhd is looking to expand its presence in Southeast Asia and Africa by supplying finished Sinovac COVID-19 vaccine manufactured by its own high-technology plant.

Group managing director Datuk Zulkarnain Md Eusope said the Southeast Asian region, with a population of over 700 million, and the African continent, with its 1.3 billion population, offered tremendous potential for growth and would be the company’s focus areas to supply the vaccine.